These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 32722718)
1. Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. Keek S; Sanduleanu S; Wesseling F; Reinout de Roest ; Michiel van den Brekel ; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P PLoS One; 2020; 15(7):e0237048. PubMed ID: 32722718 [TBL] [Abstract][Full Text] [Related]
2. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178 [TBL] [Abstract][Full Text] [Related]
3. Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer. Dragovic AF; Caudell JJ; Spencer SA; Carroll WR; Nabell LA; Bonner JA Head Neck; 2013 Mar; 35(3):381-7. PubMed ID: 22407986 [TBL] [Abstract][Full Text] [Related]
4. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review. Martens RM; Noij DP; Ali M; Koopman T; Marcus JT; Vergeer MR; de Vet H; de Jong MC; Leemans CR; Hoekstra OS; de Bree R; de Graaf P; Boellaard R; Castelijns JA Oral Oncol; 2019 Jan; 88():75-83. PubMed ID: 30616800 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy. Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958 [TBL] [Abstract][Full Text] [Related]
6. Use of Diffusion-Weighted Imaging and Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343 [TBL] [Abstract][Full Text] [Related]
7. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma. Rasmussen GB; Håkansson KE; Vogelius IR; Rasmussen JH; Friborg JT; Fischer BM; Schumaker L; Cullen K; Therkildsen MH; Bentzen SM; Specht L Acta Oncol; 2017 Nov; 56(11):1562-1570. PubMed ID: 28840766 [TBL] [Abstract][Full Text] [Related]
9. Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma. Bahig H; Lapointe A; Bedwani S; de Guise J; Lambert L; Filion E; Roberge D; Létourneau-Guillon L; Blais D; Ng SP; Nguyen-Tan PF Eur J Radiol; 2019 Jan; 110():1-6. PubMed ID: 30599844 [TBL] [Abstract][Full Text] [Related]
10. Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy. Nayak S; Bhatt MLB; Goel MM; Gupta S; Mahdi AA; Mishra A; Mehrotra D PLoS One; 2018; 13(8):e0202432. PubMed ID: 30092098 [TBL] [Abstract][Full Text] [Related]
11. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648 [TBL] [Abstract][Full Text] [Related]
12. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135 [TBL] [Abstract][Full Text] [Related]
13. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673 [TBL] [Abstract][Full Text] [Related]
14. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy]. Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807 [TBL] [Abstract][Full Text] [Related]
15. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317 [TBL] [Abstract][Full Text] [Related]
16. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma. Yuan Y; Ren J; Shi Y; Tao X Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647 [TBL] [Abstract][Full Text] [Related]
17. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma. Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835 [TBL] [Abstract][Full Text] [Related]
18. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials. Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403 [TBL] [Abstract][Full Text] [Related]
19. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma. Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247 [TBL] [Abstract][Full Text] [Related]
20. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation. Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]